id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-E-0475-0007,FDA,FDA-2013-E-0475,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2016-12-29T17:06:41Z,,0,0,090000648243db48
FDA-2013-E-0475-0006,FDA,FDA-2013-E-0475,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2015-12-28T05:00:00Z,2015,12,2015-12-28T05:00:00Z,,2015-12-29T01:58:32Z,,0,0,0900006481dd6019
FDA-2013-E-0475-0005,FDA,FDA-2013-E-0475,"Determination of Regulatory Review Period for Purposes of Patent
Extension; ELVITEGRAVIR",Notice,Determinations,2015-04-13T04:00:00Z,2015,4,2015-04-13T04:00:00Z,2015-10-14T03:59:59Z,2015-04-13T13:49:37Z,2015-08362,0,0,0900006481aa1d2c
FDA-2013-E-0475-0004,FDA,FDA-2013-E-0475,"Letter from U.S. Patent Trademark Office re Stribild, 7,176,220",Other,Letter(s),2014-12-22T05:00:00Z,2014,12,2014-12-22T05:00:00Z,,2014-12-22T22:38:31Z,,0,0,090000648198d0e4
FDA-2013-E-0475-0003,FDA,FDA-2013-E-0475,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2013-07-23T04:00:00Z,2013,7,2013-07-23T04:00:00Z,,2024-03-15T12:52:32Z,,0,0,0900006481375a9b
FDA-2013-E-0475-0001,FDA,FDA-2013-E-0475,"JAPAN TOBACCO INC. (Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P.) - Patent Extension Application",Other,Application,2013-04-23T04:00:00Z,2013,4,2013-04-23T04:00:00Z,,2013-04-23T14:25:02Z,,0,0,09000064812a2d21
FDA-2013-E-0475-0002,FDA,FDA-2013-E-0475,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2013-04-23T04:00:00Z,2013,4,2013-04-23T04:00:00Z,,2013-04-23T14:25:03Z,,0,0,09000064812a2d23